Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
34.48
-4.49 (-11.52%)
At close: May 18, 2026, 4:00 PM EDT
32.23
-2.25 (-6.53%)
Pre-market: May 19, 2026, 5:33 AM EDT
Sutro Biopharma Market Cap
Sutro Biopharma has a market cap or net worth of $571.26 million as of May 19, 2026. Its market cap has increased by 515.59% in one year.
Market Cap
571.26M
Enterprise Value
382.33M
1-Year Change
515.59%
Ranking
Category
Stock Price
$34.48
Market Cap Chart
Since September 27, 2018, Sutro Biopharma's market cap has increased from $346.92M to $571.26M, an increase of 64.67%. That is a compound annual growth rate of 6.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 571.26M | 479.55% |
| Dec 31, 2025 | 98.57M | -35.03% |
| Dec 31, 2024 | 151.72M | -41.98% |
| Dec 29, 2023 | 261.49M | -43.69% |
| Dec 30, 2022 | 464.40M | -32.55% |
| Dec 31, 2021 | 688.50M | -30.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| First Tracks Biotherapeutics | 622.48M |
| Aclaris Therapeutics | 615.92M |
| CorMedix | 611.14M |
| Gyre Therapeutics | 585.69M |
| Crescent Biopharma | 583.83M |
| Candel Therapeutics | 582.50M |
| Arvinas | 569.40M |
| Valneva SE | 544.53M |